Outcomes | Â | All Studies | Good Quality Studies | |||||
---|---|---|---|---|---|---|---|---|
 | N | Patients | RR (95%CI) | P | N | Patients | RR (95%CI) | P |
Tumor response | 27 | 1849 | 1.19[1.07,1.32] | 0.001 | 9 | 640 | 1.16[0.98,1.38] | 0.08 |
KPS | 20 | 1336 | 1.57[1.45,1.70] | <0.00001 | 4 | 296 | 1.45[1.25,1.68] | <0.00001 |
WBC | 20 | 1463 | 0.37[0.29,0.47] | <0.00001 | 7 | 510 | 0.32[0.21,0.48] | <0.00001 |
PLT | 18 | 1335 | 0.33[0.21,0.52] | <0.00001 | 6 | 450 | 0.21[0.09,0.50] | 0.0005 |
HB | 15 | 1161 | 0.44[0.30,0.66] | <0.001 | 5 | 362 | 0.37[0.19,0.72] | 0.003 |
Nausea and Vomiting | 14 | 1031 | 0.32[0.22,0.47] | <0.00001 | 5 | 389 | 0.41[0.22,0.77] | 0.006 |